Treatment of Perianal Fistulas in Crohn’s Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial - Concepedia

Concepedia

Publication | Open Access

Treatment of Perianal Fistulas in Crohn’s Disease, Seton Versus Anti-TNF Versus Surgical Closure Following Anti-TNF [PISA]: A Randomised Controlled Trial

DOI Full Paper Access

111

Citations

11

References

2020

Year

K Wasmann, E. Joline de Groof, M E Stellingwerf, Geert D’Haens, Cyriel Y. Ponsioen, K Gecse, Marcel G. W. Dijkgraaf, Michael F. Gerhards, Jeroen M. Jansen, Apollo Pronk,

Journal of Crohn s and Colitis

Abstract

The results imply that chronic seton treatment should not be recommended as the sole treatment for perianal Crohn's fistulas.

References

	Year	Citations
Infliximab for the Treatment of Fistulas in Patients with Crohn's Disease Daniel H. Present, Paul Rutgeerts, Stephan Targan, New England Journal of Medicine	1999	2.7K
Assessing the Gold Standard — Lessons from the History of RCTs Laura E. Bothwell, Jeremy A. Greene, Scott H. Podolsky, New England Journal of Medicine ReliabilityGold StandardEconomicsPhilosophy Of MedicineHealth Policy	2016	634
Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease. G Hellers, O Bergstrand, S Ewerth, Gut Primary TreatmentAnal FistulaeGastroenterologyAnal FistulaStockholm County	1980	475
Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease G. Van Assche, Dirk Vanbeckevoort, Didier Bielen, The American Journal of Gastroenterology	2003	378
Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease Gert Van Assche The American Journal of Gastroenterology Abdominal ImagingGastroenterologyPerianal Fistulizing CrohnSurgeryUlcerative Colitis	2003	314
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy Simon Lichtiger, DG Binion, Douglas C. Wolf, Alimentary Pharmacology & Therapeutics	2010	184
Does Infliximab Infusion Impact Results of Operative Treatment for Crohn's Perianal Fistulas? Wolfgang B. Gaertner, Alejandra Decanini, Anders Mellgren, Diseases of the Colon & Rectum	2007	110
Interpretation of Clinical Trials That Stopped Early Kert Viele, Anna McGlothlin, Kristine Broglio JAMA Website Uses CookiesHealth SciencesClinical EndpointPatient SafetyClinical Trials	2016	48
Clinical advantages of combined seton placement and infliximab maintenance therapy for perianal fistulizing Crohn's disease: when and how were the seton drains removed? Shinnosuke Tanaka, Katsuichi Matsuo, Takamitsu Sasaki, PubMed	2010	47
Multimodal treatment of perianal fistulas in Crohn’s disease: seton versus anti-TNF versus advancement plasty (PISA): study protocol for a randomized controlled trial E. Joline de Groof, Christianne J. Buskens, Cyriel Y. Ponsioen, Trials	2015	43

Page 1